These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30518267)

  • 1. Management of bacterial skin and skin structure infections with polymicrobial etiology.
    Esposito S; Ascione T; Pagliano P
    Expert Rev Anti Infect Ther; 2019 Jan; 17(1):17-25. PubMed ID: 30518267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?
    Caínzos M
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complicated skin and soft tissue infection.
    Dryden MS
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 3():iii35-44. PubMed ID: 20876627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to stratify patients at risk for resistant bugs in skin and soft tissue infections?
    Guillamet CV; Kollef MH
    Curr Opin Infect Dis; 2016 Apr; 29(2):116-23. PubMed ID: 26779773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical guide to the treatment of complicated skin and soft tissue infections.
    Fung HB; Chang JY; Kuczynski S
    Drugs; 2003; 63(14):1459-80. PubMed ID: 12834364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
    Cardona AF; Wilson SE
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
    Tsoulas C; Nathwani D
    Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Daptomycin in complicated skin and soft tissue infections].
    Barberán J; Fariñas MC
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():33-7. PubMed ID: 22541973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients.
    Walsh TL; Chan L; Konopka CI; Burkitt MJ; Moffa MA; Bremmer DN; Murillo MA; Watson C; Chan-Tompkins NH
    BMC Infect Dis; 2016 Nov; 16(1):721. PubMed ID: 27899072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe soft tissue infections.
    Napolitano LM
    Infect Dis Clin North Am; 2009 Sep; 23(3):571-91. PubMed ID: 19665084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
    Hau T
    Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):491-8. PubMed ID: 12172739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance to antibiotic guidelines leads to more appropriate use of antibiotics in skin and soft tissue infections in injecting drug users.
    Nymoen Aasbrenn M; Skeie I; Berild D
    Infect Dis (Lond); 2019 Aug; 51(8):570-577. PubMed ID: 31144548
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of multidrug and extensive-drug resistant Gam-negative bacteria in skin and soft tissue infections.
    Brink AJ; Richards GA
    Curr Opin Infect Dis; 2020 Apr; 33(2):93-100. PubMed ID: 31990811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship.
    Jenkins TC; Sabel AL; Sarcone EE; Price CS; Mehler PS; Burman WJ
    Clin Infect Dis; 2010 Oct; 51(8):895-903. PubMed ID: 20839951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of bacterial skin and soft tissue infections.
    Garlicki AM; Jawień M; Pancewicz S; Moniuszko-Malinowska A; Kalinowska-Nowak A; Bociąga-Jasik M
    Przegl Epidemiol; 2020; 74(1):89-107. PubMed ID: 32500989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-Negative Skin and Soft Tissue Infections.
    Jabbour JF; Kanj SS
    Infect Dis Clin North Am; 2021 Mar; 35(1):157-167. PubMed ID: 33303333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.
    Takimoto K; Wang Q; Suzuki D; Katayama M; Hayashi Y
    Expert Opin Pharmacother; 2017 Jul; 18(10):1027-1034. PubMed ID: 28627952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Pathogens in Skin and Soft-Tissue Infections and Pedal Osteomyelitis in Puncture Wound Injuries Affecting the Foot.
    Truong DH; Fontaine J; Malone M; Wukich DK; Davis KE; Lavery LA
    J Am Podiatr Med Assoc; 2022; 112(6):. PubMed ID: 33141882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections.
    Morgan A; Cofer C; Stevens DL
    Future Microbiol; 2009 Mar; 4(2):131-44. PubMed ID: 19257839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.